Status:
UNKNOWN
Conventional vs Ultrathin Bronchoscopy for Peripheral Pulmonary Lesions
Lead Sponsor:
Stefano Gasparini
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study's purpose is to evaluate whether the use of an ultra-thin bronchoscope can improve sensitivity and diagnostic yield in peripheral pulmonary nodules. The ultra-thin probe is expected to reac...
Detailed Description
142 patients with at least one peripheral pulmonary nodule will be enrolled. They will underwent randomization in 2 arms: patients in the first arm will undergo transbronchial needle aspiration with a...
Eligibility Criteria
Inclusion
- age ≥ 18years;
- presence of at least one peripheral pulmonary lesion ≤ 3 cm on CT scan;
- ability to give an informed consent.
Exclusion
- coagulopathy or bleeding diathesis that cannot be corrected;
- severe refractory hypoxemia;
- unstable hemodynamic status;
- inability to give an informed consent.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04029155
Start Date
July 1 2022
End Date
June 1 2023
Last Update
May 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.